Evidence map›Paper›PMID 42100272›Full record

ReviewFrontiers in medicine2026

Diagnosis and treatment of breast cancer during pregnancy: a comprehensive review.

Jiuxing Wei, Fengjiang Qu, Tinghan Jiang, Chengzhao Xu

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiuxing WeiDepartment of Emergency Surgery, The First Hospital of Jilin University, Changchun, Jilin, China.
Fengjiang QuDepartment of Emergency Surgery, The First Hospital of Jilin University, Changchun, Jilin, China.
Tinghan JiangHepatobiliary Pancreatic Surgery Department II, General Surgery Center, First Hospital of Jilin University, Changchun, China.
Chengzhao XuDepartment of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer during pregnancy (BCP) is clinically rare. Its occurrence during a unique physiological period introduces pregnancy-related complications that can seriously affect maternal health. Diagnostic and treatment criteria are lacking. Nowadays, breast cancer (BC) has surpassed lung cancer and become the most common malignant tumor in the world, posing a serious threat to women's physical and mental health. BCP is a rare malignant tumor with unique characteristics for diagnosis and treatment. Diagnosing cancer at this particular time in a woman's life is a challenge in clinical management because of the need to ensure psychological safety and pregnancy status. Lack of systematic diagnosis and treatment plans can affect patient outcomes. By reviewing the literature at home and abroad, we summarized the status of diagnosis and treatment of BCP as well as the controversial issues for clinical application, highlighting the evolutionary trajectory of management strategies in this field.

Indexed as

breast cancerdiagnosisevolutionpregnancytreatment

Identifiers

PMID42100272
PMCPMC13144061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.